SOX2 and non-small cell lung carcinoma: In NSCLC, SOX2 upregulates IL6 via FOS-like antigen 2, promoting inflammation and metastasis while suppressing CD8+ T cell infiltration via cyclic GMP-AMP synthase/STING degradation (111).